Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 14, 2007, Pages 6013-6018

  Suzuki, Shotaro ^a,b   Brown, Candice M ^a,b   Dela Cruz, Christopher D ^b   Yang, Enhua ^b   Bridwell, David A ^b   Wise, Phyllis M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; Ischemic injury stroke; Women's health initiative

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; ANTIINFLAMMATORY AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NEUROPROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; INFLAMMATION; MOUSE; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT DURATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; BLOOD; BRAIN ISCHEMIA; C57BL MOUSE; COMPARATIVE STUDY; DOWN REGULATION; DRUG IMPLANT; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHEMOKINE CCL2; DOWN-REGULATION; DRUG IMPLANTS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; OVARIECTOMY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34347244941     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0610394104     Document Type: Article

References (51)

1. Bushnell CD (2006) Semin Neurol 26:123-130.
2. Mitka M (2006) JAMA 295:1755-1756.
3. Paganini-Hill A (2001) Maturitas 38:243-261.
4. Turgeon JL, McDonnell DP, Martin KA, Wise PM (2004) Science 304:1269-1273.
5. Behl C (2002) Nat Rev Neurosci 3:433-442.
6. McCullough LD, Hum PD (2003) Trends Endocrinol Metab 14:228-235.
7. Wise PM, Dubal DB, Rau SW, Brown CM, Suzuki S (2005) Endocr Rev 26:308-312.
8. Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM (2006) Endocr Rev 27:575-605.
9. Viscoli CM, Brass LM, Kernan WN (2001) N Engl J Med 345:1243-1249.
10. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al. (2002) JAMA 288:321-333.
11. Miller VM, Clarkson TB, Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Naftolin F, Santoro N (2005) J Appl Physiol 99:381-383.
12. Harman SM, Naftolin F, Brinton EA, Judelson DR (2005) Ann N Y Acad Sci 1052:43-56.
13. Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V (2001) Neurol Sci 22:289-296.
14. Vila N, Castillo J, Davalos A, Chamorro A (2000) Stroke 31:2325-2329.
15. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M (1994) J Neurol Sci 122:135-139.
16. Reynolds MA, Kirchick HJ, Dahlen JR. Anderberg JM, McPherson, PH, Nakamura KK, Laskowitz DT, Valkirs GE, Buechler KF (2003) Clin Chem 49:1733-1739.
17. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD (2006) J Cereb Blood Flow Metab 26:654-665.
18. Clark WM, Rinker LG, Lessov NS, Hazel K, Eckenstein FP (1999) Neurol Res 21:287-292.
19. Dubai DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM (1998) J Cereb Blood Flow Metab 18:1253-1258.
20. Dubal DB, Zhu B, Yu B, Rau SW, Shughrue PJ, Merchcnthaler I, Kindy MS, Wise PM (2001) Proc Natl Acad Sci USA 98:1952-1957.
21. Rau SW, Dubal DB, Bottner M, Gerhold LM, Wise PM (2003) J Neurosci 23:11420-11426.
22. Vegeto E, Belcredito S, Ghisletti S, Meda C, Etteri S, Maggi A (2006) Endocrinology 147:2263-2272.
23. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A, Dupont S, Ciana P, Chambon P, Maggi A (2003) Proc Natl Acad Sci USA 100:9614-9619.
24. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM (1999) J Neurosci 19:6385-6393.
25. Dubal DB, Rau SW, Shughrue PJ, Zhu H, Yu J, Cashion AB, Suzuki S, Gerhold LM, Bottncr MB, Dubai SB, et al. (2006) Endocrinology 147:3076-3084.
26. Suzuki S, Brown CM, Wise PM (2006) Endocrine 29:209-215.
27. Wassertheil-Smoller S, Hendrix SL, Limacher M (2003) JAMA 289:2673-2684.
28. Che X, Ye W, Panga L, Wu DC, Yang GY (2001) Brain Res 902:171-177.
29. Chen Y, Hallenbeck JM, Ruetzler C, Bol D, Thomas K, Berman NEJ, Vogel SN (2003) J Cereb Blood Flow Metab 23:748-755.
30. Kim JS, Gautam SC, Chopp M, Zaloga C, Jones ML, Ward PA, Welch KM (1995) J Neuroimmunol 56:127-134.
31. Allan SM, Rothwell NJ (2001) Nat Rev Neurosci 2:734-744.
32. Marklund N, Peltonen M, Nilsson TK, Olsson T (2004) J Intern Med 256:15-21.
33. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Grcenberg DA (2003) J Clin Invest 111:1843-1851.
34. Hayashi T, Abe K, Itoyama Y (1998) J Cereb Blood Flow Metab 18:887-895.
35. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M (2000) J Clin Invest 106:829-838.
36. Galien R, Garcia T (1997) Nucleic Acids Res 25:2424-2429.
37. Inadera H, Sekiya T, Yoshimura T, Matsushima K (2000) Endocrinology 141:50-59.
38. An J, Ribeiro RC, Webb P, Gustafsson JA, Kushner PJ, Baxter JD, Leitman DC (1999) Proc Natl Acad Sci USA 96:15161-15166.
39. Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I (2005) Curr Pharm Des 11:1017-1030.
40. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN (2000) Proc Natl Acad Sci USA 97:10972-10977.
41. Nilsen J, Chen S, Irwin RW, Iwamoto S, Brinton RD (2006) BMC Neurosci 7:74-87.
42. Zaremba J, Losy J (2001) Acta Neurol Scand 104:288-295.
43. Zaremba J, Skrobanski P, Losy J (2001) Biomed Pharmacother 55:258-263.
44. Intiso D, Zarrelli MM, Lagioia G, Rienzo F, Checchia De Ambrosio C, Simone P, Tonali P, Cioffi Dagger RP (2004) Neurol Sci 24:390-396.
45. Hallenbeck JM (2002) Nat Med 6:1363-1368.
46. St. Pierre BA, Merrill JE, Dopp JM (1996) in Cytokines and the CNS, eds Ransohoff RM, Benveniste EN (CRC Press, Boca Raton, FL), p 339.
47. Kim HM, Shin HY, Jeong HJ, An HJ, Kim NS, Chae HJ, Kim HR, Song HJ, Kim KY, Baek SH, et al. (2000) J Mol Neurosci 14:191-196.
48. Ringheim GE (1995) Neurosci Lett 201:131-134.
49. Liva SM, Vellis JD (2001) Neurochem Res 26:629-637.
50. Wilson ME, Dubal DB, Wise PM (2000) Brain Res 873:235-242.
51. Chen S, Nilsen J, Brinton RD (2006) Endocrinology 147:5303-5313.